JADEN JUERGENS: Open Payments
NPI 1538810577 · LAYTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$925 in 37 payments from 12 companies in 2025. Trend: 2023 $20 · 2024 $518 · 2025 $925
Food & beverage: $925
| Company | Payments | Amount |
|---|---|---|
| CSL Behring | 9 | $266 |
| Regeneron Healthcare Solutions, Inc. | 8 | $180 |
| GENZYME CORPORATION | 3 | $76 |
| AstraZeneca Pharmaceuticals LP | 4 | $74 |
| Phathom Pharmaceuticals, Inc. | 1 | $73 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $59 |
| Verona Pharma, Inc. | 2 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| Pharming Healthcare, Inc. | 2 | $35 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
Products named: DUPIXENT, Hizentra, VOQUEZNA, NEFFY, Ohtuvayre, TAKHZYRO, RUCONEST, XOLAIR.
Industry payments across UT — which companies pay providers there.
